Navigation Links
3 distinguished keynote speakers to present during ARVO 2013 Annual Meeting

Rockville, Md. The Association for Research in Vision and Ophthalmology 2013 Annual Meeting will feature lectures from three keynote speakers, including two Nobel laureates, during the organization's five-day conference, May 5 9 in Seattle, Wash.

New this year, the ARVO/Alcon Keynote Series will include Oliver Smithies, DPhil; Roger Tsien, PhD and Christopher Murray, MD, DPhil.

Smithies, of the University of North Carolina at Chapel Hill, is a 2007 Nobel laureate in Physiology/Medicine. His lecture, "On Being a Scientist for 60 years," will present highlights from his "deeply satisfying life in science," which includes his co-discovery of homologous DNA recombination, a technique to introduce DNA material in cells. His research has led to the creation of "designer mice," which replicate human disease such as cystic fibrosis and high blood pressure and "knock-out mice," which have become commonplace in biomedical research. His lecture will take place Sunday, May 5, 3 4:30pm.

Tsien, of the University of California, San Diego, will present "Engineering Phototransducing Molecules for Fun and Profit," a closer look at molecules that enable us to photostimulate biochemical pathways in living cells and tissues, as well as possible challenges investigators face and examples of successes and failures within his experience. He was awarded a Nobel Prize in 2008 for his discovery and development of the green fluorescent protein (GFP) with two other chemists. Tsien's lecture will be held Tuesday, May 7, 5:30 6:45pm.

Murray is a scholar in global health and public health at the University of Washington, Seattle, and the director of the Institute for Health Metrics and Evaluation. His lecture, "Global Burden of Disease Study 2010: Key Findings and Implications for Vision Research" will discuss the study with a focus on vision loss in the context of the other diseases, and injuries and risk factors that were studied to demonstrate this impairment's global impact over the past two decades and what it means for the future. Murray will present Thursday, May 9, 2 3:15pm.

For information about the ARVO 2013 Annual Meeting, visit


Contact: Katrina Norfleet
Association for Research in Vision and Ophthalmology

Related biology news :

1. UC Riverside entomologist named Distinguished Scientist of the Year
2. Biophysical Society names 2013 Distinguished Service, Emily M. Gray, and Founders awardees
3. SEBM Distinguished Scientist Awards for 2012
4. Biophysical Society announces 2013 New and Notable Symposium speakers
5. ONR lines up speakers and technologies for 2012 Naval Conference
6. World Food Prize winner among speakers at agronomy, crop and soil science societies meetings
7. Maris presentation tops ANZFSS International Symposium
8. Synthetic Biologics to Present at the 2013 BIO CEO & Investor Conference
9. Choline supplementation during pregnancy presents a new approach to schizophrenia prevention
10. Cognitive deficits from concussions still present after 2 months
11. MicroRNAs present exciting opportunities for cancer therapy and diagnosis
Post Your Comments:
(Date:11/12/2015)... 11, 2015   Growing need for low-cost, ... has been paving the way for use of ... discrete analytes in clinical, agricultural, environmental, food and ... used in medical applications, however, their adoption is ... to continuous emphasis on improving product quality and ...
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
(Date:11/9/2015)... DUBLIN , Nov. 09, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Law Enforcement Biometrics Market 2015-2019" ... Research and Markets ( ) ...
Breaking Biology News(10 mins):
(Date:11/27/2015)... CHESTERFIELD, United Kingdom , Nov. 27, 2015 /PRNewswire/--  ... specialty biopharmaceutical company, announced today that it has closed ... systems (CMDS) business to Guerbet (GBT- NYSE Euronext) in ... CMDS operations encompassed four manufacturing facilities and a total ... nearly 75 in the St. Louis ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... --> Accutest Research Laboratories, ... Contract Research Organization (CRO), has formed ... Cancer Center - Temple Health for ... ,     (Photo: ) , ...
(Date:11/25/2015)...  PharmAthene, Inc. (NYSE MKT: PIP) announced  today that ... plan (Rights Plan) in an effort to preserve the ... Section 382 of the Internal Revenue Code (Code). ... of its NOLs could be substantially limited if the ... 382 of the Code. In general, an ownership change ...
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 /PRNewswire/ ... ), a biotechnology company developing bioengineered organ implants for ... will present at the LD Micro "Main Event" ... p.m. PT. The presentation will be webcast live and ... will also be available at the conference for one-on-one ...
Breaking Biology Technology: